Vascular Dementia - Epidemiology Forecast - 2032

This ‘Vascular Dementia (VaD)- Epidemiology Forecast-2032' report delivers an in-depth understanding of the Vascular Dementia, historical and forecasted epidemiology as well as the Vascular Dementia epidemiology trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Vascular Dementia (VaD) Disease Understanding

The word dementia describes a set of symptoms that can include memory loss and difficulties with thinking, problem-solving, or language. In vascular dementia, these symptoms occur when the brain is damaged because of problems with blood supply to the brain. Vascular dementia (VaD) is an etiological category of dementia characterized by severe cognitive impairment resulting from ischemic or hemorrhagic stroke or hypoperfusion affecting brain regions important for memory, cognition, and behavior. Vascular dementia is a decline in thinking skills caused by conditions that block or reduce blood flow to various brain regions, depriving them of oxygen and nutrients. Cognition and brain function can be significantly affected by the size, location, and the number of vascular changes.

A growing number of experts prefer the term “vascular cognitive impairment” (VCI) to “vascular dementia” because they feel it better expresses the concept that vascular thinking changes can range from mild to severe. According to the Vascular Impairment of Cognition Classification Consensus Study (VICCCS) guideline, VaD can be classified into four major subtypes: Post-stroke dementia (PSD) defined as dementia manifesting within 6 months after a stroke; Subcortical ischemic vascular dementia (SIVAD); Multi-infarct (cortical) dementia; and Mixed dementia.

Vascular Dementia (VaD) Diagnosis

The diagnosis of vascular dementia should be suspected in patients with significant vascular risk factors, stroke, or heart disease who exhibit abrupt changes in cognition. Brain imaging demonstrating the presence of relevant lesions of cerebrovascular disease is crucial for diagnosing vascular dementia.

Vascular Dementia (VaD) Epidemiology Perspective

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by total prevalent cases of dementia, diagnosed prevalent cases of dementia, diagnosed prevalent cases of vascular dementia and age-specific diagnosed prevalent cases of vascular dementia in scenario of Vascular Dementia (VaD) in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2019 to 2032.

Vascular Dementia Detailed Epidemiology Segmentation

• As per the assessment of the publisher, total prevalent cases of dementia in the 7MM were found to be 21,591,565 in 2021, which are expected to increase at a Compound Annual Growth Rate (CAGR) of 2.42% during study period.
• The diagnosed prevalent cases of dementia in the 7MM were found to be 11,344,408 in 2021, which are expected to increase at a CAGR of 3.60% for the study period of 2019-2032.
• As per the publisher's estimates, 7MM accounts for 2,795,390 diagnosed prevalent cases of VaD in 2021, which are expected to increase at a CAGR of 3.60%.
• Among 7MM, the United States has the highest diagnosed cases of VaD with 1,110,606 cases in 2021, equivalent to 40% of total diagnosed prevalent cases in the 7MM.
• Vascular Dementia (VaD) is highly prevalent in age group of 60 years and above, while below this age group the disease appears to be rare. Thus, we have stratified diagnosed prevalence cases in the age group of 60-70 years, 71-80 years, 81-90 years, and ≥91 years.
• In 2021, the EU-5 accounts for 893,124 diagnosed prevalent cases of VaD, which will increase by 2032 at a CAGR of 3.26%.
• In 2021, Japan had 791,660 diagnosed cases of VaD ranking second-highest among 7MM. These cases are expected to increase by 2032 at a CAGR of 3.37% during the forecasted period (2022-2032).

Scope of the Report

• The report covers the descriptive overview of Vascular Dementia, explaining its symptoms, etiology, pathogenesis, and various diagnostic approaches.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report assesses the disease risk and burden of Vascular Dementia.
• The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
• The report provides the segmentation of the disease epidemiology for 7MM total prevalent cases of dementia, diagnosed prevalent cases of dementia, diagnosed prevalent cases of vascular dementia and age-specific diagnosed prevalent cases of vascular dementia.

Report Highlights

• 11-Year Forecast of Vascular Dementia
• 7MM Coverage
• Total Prevalent Cases of Dementia
• Diagnosed Prevalent Cases of Dementia
• Diagnosed Prevalent Cases of Vascular Dementia
• Age-specific Diagnosed Prevalent Cases of Vascular Dementia

Key Questions Answered

• What are the disease risk and burdens of Vascular Dementia (VaD)?
• What is the historical Vascular Dementia (VaD) patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
• What would be the forecasted patient pool of Vascular Dementia (VaD) at the 7MM level?
• What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Vascular Dementia (VaD)?
• Out of the above-mentioned countries, which country would have the highest patient population of Vascular Dementia (VaD) during the forecast period (2022-2032)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2022-2032)?

Reasons to Buy

The Vascular Dementia (VaD) report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the 7MM Vascular Dementia (VaD) epidemiology forecast.
• The Vascular Dementia (VaD) epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
• The Vascular Dementia (VaD) epidemiology model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032